PGNY - CIK 0001551306
The table below shows Progyny, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $210.19M | $179.10M | $188.81M | $80.39M | $26.04M | $36.20M |
| Capital expenditure | $18.41M | $5.41M | $3.64M | $3.24M | $2.13M | $1.04M |
| Investing cash flow | -$159.01M | $195.79M | -$200.53M | -$43.87M | $8.77M | -$40.03M |
| Dividends paid | - | - | - | - | - | - |
Progyny, Inc. reported operating cash flow of $210.19M for fiscal year 2025. That is up 17.4% from $179.10M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow grew from -$9.47M (FY 2017) to $210.19M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $81.66M | $300.28M | $0.00 | $0.00 | - | - |
| Financing cash flow | -$99.36M | -$309.88M | -$11.07M | -$7.86M | -$13.70M | -$6.25M |